Ventricular Assist Device Implantation and the Risk for Heparin-Induced Thrombocytopenia

Annals of Thoracic Surgery

Volumn 85, Issue 1, 2008, Pages 360-361

  Barzaghi, Nicoletta ^a   Locatelli, Alessandro ^a   Ranucci, Marco ^b  

^a S CROCE E CARLE HOSPITAL   (Italy)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGATROBAN; CARBON 14; DANAPAROID; FONDAPARINUX; HEPARIN; HIRULOG; LEPIRUDIN; SEROTONIN; WARFARIN;

ANTICOAGULANT THERAPY; ASSISTED CIRCULATION; DEVICE; DRUG HALF LIFE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INCIDENCE; LABORATORY TEST; LETTER; PRIORITY JOURNAL; SEROLOGY; THROMBOCYTOPENIA;

FEMALE; HEART-ASSIST DEVICES; HEPARIN; HUMANS; INCIDENCE; MALE; PROGNOSIS; RISK ASSESSMENT; THROMBOCYTOPENIA; THROMBOEMBOLISM;

EID: 37249030386     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.06.010     Document Type: Letter

References (3)

1. Koster A., Huebler S., Potapov E., et al. Impact of heparin-induced trombocypopenia on outcome in patients with ventricular assist device support: single-institution experience in 358 consecutive patients. Ann Thorac Surg 83 (2007) 72-76
2. Warkentin T.E., and Crowther M.A. When is HIT really HIT?. Ann Thorac Surg 83 (2007) 21-23
3. Arepally G.M., and Ortel T.L. Heparin-induced thrombocypotenia. N Engl J Med 355 (2006) 809-817